Figure 1. Chemical Structure Of Valrubicin (Val 1)
Valrubicin Intravesical Solution Solution, Concentrate
Product Images NDC 24201-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valrubicin Intravesical Solution (NDC 24201-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2. Comparison Of Mean Auc0-6 Hours In Valrubicin Intravesical Solution Clinical Studies (n=number Of Patients) (Val 2)
The text provided is a table showing values of mean AUC in clinical studies comparing Valrubicin Intravesical Solution for 0-6 hours. The table also includes different treatment options such as Two Weeks Typical TUR, Extensive Perforated IV Infusion, and Patient Subset. There is no further information available.*
Vial Label (Val 3)
Carton Image (Val 4)
This appears to be a description of a medication called Valrubicin Intravesical Solution, with warnings and instructions for its proper use. It is not recommended for intramuscular or intravenous use and should not be administered undiluted. Each milliliter contains 40 mg of Valbin and is packaged in single-dose vials. Unused portions should be discarded and the medication is described as sterile, non-pyrogenic, and preservative-free.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
